Sponsor

Elisabeth-TweeSteden Ziekenhuis

Clinical research sponsor

Published trials8

Recruiting shown2

Roles1

SourceClinicalTrials.gov

Clinical trials

8 shown

Supplemental Screening for Women With Extremely Dense Breast Tissue: the DENSE-2 TrialNCT06636370 · collaborator · 2024-11-11

RECRUITING

The Beneficial Value of PET/CT in the Follow-up of Stage III Non-small Cell Lung Cancer PatientsNCT06082492 · collaborator · 2024-03-19

RECRUITING

Prospective Assessment of Cost-effectiveness and Side-effects of Depressive Patients Treated With ECT or TCANCT05306184 · collaborator · 2022-01-01

ACTIVE_NOT_RECRUITING

2000HIV Trained Innate Immunity in HIV Elite ControllersNCT04968717 · collaborator · 2021-08-02

COMPLETED

Defining the Potency of DTG/3TC for Suppressed HIV Patients in Real-life: the DUALING StudyNCT04707326 · collaborator · 2019-11-01

ACTIVE_NOT_RECRUITING

2000 HIV Human Functional Genomics Partnership ProgramNCT03994835 · collaborator · 2019-10-16

COMPLETED

Prospective Evaluation of the Non-invasive ICP HeadSense Monitor in TBI Patients Undergoing Invasive ICP MonitoringNCT02773862 · collaborator · 2014-06-01

COMPLETED

TweeSteden Mild Stenosis StudyNCT01788241 · collaborator · 2009-01-01

UNKNOWN

Sponsor roles

collaborator8

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.